ORAL THEOPHYLLINE DISPOSITION IN CYSTIC-FIBROSIS
- 1 January 1982
- journal article
- research article
- Vol. 48 (3) , 175-177
Abstract
Theophylline absorption and disposition in CF [cystic fibrosis] patients have not been systematically studied. To evaluate these factors in CF subjects, 7 CF patients were fasted overnight and administered a dose of aminophylline liquid equivalent to 4 mg/kg anhydrous theophylline. Liver function tests (SGOT, [serum glutamicoxalacetic transaminase], GGT [glutamyl transferase] alkaline phosphatase) were normal in all 7 patients. Maximum serum theophylline concentrations occurred 30-60 min post-dose in all subjects and ranged from 4.8- 8.6 .mu.g/ml. These values are similar to those reported in non-CF subjects for a single 4 mg/kg oral dose. The mean serum half-life of 3.5 h with a range of 1.2-5.0 h is similar to that reported in non-CF populations. Evidently, theophylline elimination (half-lives) in CF patients with normal liver function is similar to those of normal and asthmatic patients. CF patients with clinical liver disease may have a decreased clearance and should be carefully monitored.This publication has 7 references indexed in Scilit:
- Intravenous Aminophylline in Patients With Cystic FibrosisAmerican Journal of Diseases of Children, 1980
- BRONCHIAL REACTIVITY IN CYSTIC-FIBROSIS1978
- Clinical Pharmacokinetics of TheophyllineClinical Pharmacokinetics, 1978
- The Paradoxical Effect of Adrenergic and Methylxanthine Drugs in Cystic FibrosisPediatrics, 1976
- Pharmacokinetics of Theophylline in Children With AsthmaPediatrics, 1976
- Pharmacokinetic analysis of the disposition of intravenous theophylline in young childrenThe Journal of Pediatrics, 1976
- Intrinsic (nonallergic) bronchial asthma as a manifestation of fibrocystic disease of the pancreasJournal of Allergy, 1957